Reviews in Cardiovascular Medicine Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management
Heat Failure University Previous articles | Next articles
Sandeep K. Krishnan, Norman E. Lepor
Hyperkalemia is a common electrolyte disorder associated with life-threatening cardiac arrhythmias and increased mortality. Patients at greatest risk for hyperkalemia include those with diabetes and those with impaired renal function in whom a defect in the excretion of renal potassium may already exist. Hyperkalemia is likely to become more common clinically because angiotensin receptor blockers and angiotensin-converting enzyme inhibitors are increasingly being used in higher doses and are thought to confer cardiovascular and renal protection. Until recently, options for treating hyperkalemia were limited to the use of thiazide and loop diuretics and sodium polystyrene sulfonate. Newer options such as sodium zirconium cyclosilicate will allow for the safe and effective treatment of hyperkalemia while maintaining patients on prescribed renin- angiotensin-aldosterone system inhibitors.
Key words: Hyperkalemia Potassium Chronic kidney disease Congestive heart failure Patiromer Sodium zirconium cyclosilicate
Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9-21.	
[9] Matthew M. Schumaecker, Timothy R. Larsen, , David C. Sane. Cardiac Manifestations of Adrenal Insufficiency[J]. Reviews in Cardiovascular Medicine, 2016, 17(3-4): 131-136.
[15] Alberto Palazzuoli, Matteo Beltrami, Savina Nodari, Peter A. McCullough, Claudio Ronco. Clinical Impact of Renal Dysfunction in Heart Failure[J]. Reviews in Cardiovascular Medicine, 2011, 12(4): 186-199.